Table 2 Clinicopathologic characteristics of eIF6 expression in HCC patients

All cases

68

44

24

Gender

 Male

59

37 (62.7%)

22 (37.3%)

0.765

0.382

 Female

9

7 (77.8%)

2 (22.2%)

Age

 ≤ 57

34

21(61.8%)

13(38.2%)

0.258

0.612

 > 57

34

23(67.6%)

11(32.4%)

Tumour size (diameter in cm)

 < 6

33

15 (45.5%)

18 (54.5%)

10.405

0.001

 ≥ 6

35

29 (82.9%)

6 (17.1%)

Differentiation

 Well

9

6 (66.7%)

3 (33.3%)

0.286

0.355

 Moderate

52

35 (67.3%)

17 (32.7%)

 Poor

7

4 (57.1%)

3 (42.9%)

Vascular invasion

 No

28

11 (39.3%)

17 (60.7%)

13.468

0.000

 Yes

40

33 (82.5%)

7 (17.5%)

Lymphatic metastasis

 No

50

31 (62.0%)

19 (38.0%)

0.230

0.632

 Yes

18

10 (55.6%)

8 (44.4%)

Distant metastasis

 No

41

25 (61.0%)

16 (39.0%)

0.629

0.428

 Yes

27

19 (70.4%)

8 (29.6%)

Hepatitis B

 No

19

11 (57.9%)

8 (42.1%)

0.043

0.835

 Yes

49

27 (55.1%)

22 (44.9%)

AFP level ( ng /ml)

 ≤ 400

53

34 (64.2%)

19 (35.8%)

0.032

0.857

 > 400

15

10 (66.7%)

5 (33.3%)

Cirrhosis

 No

33

24 (72.7%)

9 (27.3%)

1.806

0.179

 Yes

35

20 (57.1%)

15 (42.9%)